These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22699931

  • 1. Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
    Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Moon IH, Rhee JC.
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1743-51. PubMed ID: 22699931
    [Abstract] [Full Text] [Related]

  • 2. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 3. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer.
    Ahn DW, Seo JK, Lee SH, Hwang JH, Lee JK, Ryu JK, Kim YT, Yoon YB.
    Pancreas; 2012 Oct; 41(7):1048-57. PubMed ID: 22513291
    [Abstract] [Full Text] [Related]

  • 4. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

  • 5. KML001 inhibits cell proliferation and invasion in pancreatic cancer cells through suppression of NF-κB and VEGF-C.
    Yang MH, Kim HT, Lee KT, Yang S, Lee JK, Lee KH, Rhee JC.
    Anticancer Res; 2014 Jul; 34(7):3469-74. PubMed ID: 24982355
    [Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 7. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. KML001 enhances anticancer activity of gemcitabine against pancreatic cancer cells.
    Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Rhee JC.
    Anticancer Res; 2015 Jan 15; 35(1):183-9. PubMed ID: 25550550
    [Abstract] [Full Text] [Related]

  • 10. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ.
    Int J Oncol; 2011 Nov 01; 39(5):1123-31. PubMed ID: 21743963
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 01; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

  • 16. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation.
    Zhuang Z, Li H, Lee H, Aguilar M, Gocho T, Ju H, Iida T, Ling J, Fu J, Wu M, Sun Y, Lu Y, Chiao PJ.
    Cancer Lett; 2017 Dec 28; 411():44-56. PubMed ID: 28951128
    [Abstract] [Full Text] [Related]

  • 17. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
    Kim BH, Yoon JH, Yang JI, Myung SJ, Lee JH, Jung EU, Yu SJ, Kim YJ, Lee HS, Kim CY.
    J Gastroenterol Hepatol; 2013 Dec 28; 28(12):1859-68. PubMed ID: 23808824
    [Abstract] [Full Text] [Related]

  • 18. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.
    Mol Cancer; 2011 Aug 16; 10():98. PubMed ID: 21843371
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.